Canada Reportedly Ready to Cave on CETA Drug Patent Demands

Wednesday November 14, 2012
The Canadian Press reports that Canada is ready to cave to European demands for changes to patent rules that could cost Canadians hundreds of millions of dollars in higher health care costs. The ministerial meeting on the remaining CETA issues is set for next week.